JP2006501165A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501165A5
JP2006501165A5 JP2004510817A JP2004510817A JP2006501165A5 JP 2006501165 A5 JP2006501165 A5 JP 2006501165A5 JP 2004510817 A JP2004510817 A JP 2004510817A JP 2004510817 A JP2004510817 A JP 2004510817A JP 2006501165 A5 JP2006501165 A5 JP 2006501165A5
Authority
JP
Japan
Prior art keywords
peptide
composition
subject
exposed
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004510817A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501165A (ja
JP4460445B2 (ja
Filing date
Publication date
Priority claimed from US10/165,250 external-priority patent/US20030108539A1/en
Application filed filed Critical
Publication of JP2006501165A publication Critical patent/JP2006501165A/ja
Publication of JP2006501165A5 publication Critical patent/JP2006501165A5/ja
Application granted granted Critical
Publication of JP4460445B2 publication Critical patent/JP4460445B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004510817A 2002-06-07 2003-06-09 Ｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤 Expired - Lifetime JP4460445B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/165,250 US20030108539A1 (en) 2000-02-14 2002-06-07 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
PCT/IB2003/003094 WO2003103698A1 (en) 2002-06-07 2003-06-09 Cell-permeable peptide inhibitors of the jnk signal transduction pathway

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009272904A Division JP2010053136A (ja) 2002-06-07 2009-11-30 Ｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤

Publications (3)

Publication Number Publication Date
JP2006501165A JP2006501165A (ja) 2006-01-12
JP2006501165A5 true JP2006501165A5 (https=) 2010-02-18
JP4460445B2 JP4460445B2 (ja) 2010-05-12

Family

ID=29732060

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004510817A Expired - Lifetime JP4460445B2 (ja) 2002-06-07 2003-06-09 Ｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤
JP2009272904A Withdrawn JP2010053136A (ja) 2002-06-07 2009-11-30 Ｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009272904A Withdrawn JP2010053136A (ja) 2002-06-07 2009-11-30 Ｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤

Country Status (14)

Country Link
US (1) US20030108539A1 (https=)
EP (7) EP1511507B1 (https=)
JP (2) JP4460445B2 (https=)
AT (2) ATE372125T1 (https=)
AU (1) AU2003274820B2 (https=)
CA (1) CA2488695C (https=)
CY (3) CY1108847T1 (https=)
DE (2) DE60316149D1 (https=)
DK (2) DK1776958T5 (https=)
ES (3) ES2439950T3 (https=)
HK (1) HK1207971A1 (https=)
PT (3) PT1776958E (https=)
SI (1) SI1776958T1 (https=)
WO (1) WO2003103698A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8183339B1 (en) 1999-10-12 2012-05-22 Xigen S.A. Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US20040082509A1 (en) 1999-10-12 2004-04-29 Christophe Bonny Cell-permeable peptide inhibitors of the JNK signal transduction pathway
EP1656951A1 (en) * 2004-11-12 2006-05-17 Xigen S.A. Conjugates with enhanced cell uptake activity
EP1661912A1 (en) * 2004-11-29 2006-05-31 Xigen S.A. Fusion protein comprising a BH3-domain of a BH3-only protein
US20060223807A1 (en) 2005-03-29 2006-10-05 University Of Massachusetts Medical School, A Massachusetts Corporation Therapeutic methods for type I diabetes
WO2007031098A1 (en) * 2005-09-12 2007-03-22 Xigen S.A. Cell-permeable peptide inhibitors of the jnk signal transduction pathway
US8080517B2 (en) * 2005-09-12 2011-12-20 Xigen Sa Cell-permeable peptide inhibitors of the JNK signal transduction pathway
EP2074138A4 (en) 2006-09-19 2009-12-30 Phylogica Ltd NEUROPROTECTIVE PEPTIDE AP-1 SIGNALING INHIBITORS AND USES THEREOF
KR20090115852A (ko) * 2007-01-19 2009-11-09 카이 파마슈티컬즈 안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형
EP2170932A4 (en) 2007-06-20 2012-10-10 Phylogica Ltd COMPOSITIONS AND APPLICATIONS THEREOF IN THE TREATMENT OF ACUTE ATOMIC SYNDROME (ARDS) AND ASSOCIATED CLINICAL ILLNESSES
WO2009143864A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
WO2009143865A1 (en) * 2008-05-30 2009-12-03 Xigen S.A. Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
WO2010072228A1 (en) * 2008-12-22 2010-07-01 Xigen S.A. Novel transporter constructs and transporter cargo conjugate molecules
CN102365093A (zh) * 2009-03-30 2012-02-29 参天制药株式会社 用于视网膜疾病的预防剂或治疗剂和使用JNK(c-Jun氨基末端激酶)抑制肽预防或治疗视网膜疾病的方法以及所述肽的用途
JP5457813B2 (ja) * 2009-12-16 2014-04-02 ルネサスエレクトロニクス株式会社 Ａｄｐｌｌ回路、半導体装置及び携帯情報機器
WO2011160653A1 (en) 2010-06-21 2011-12-29 Xigen S.A. Novel jnk inhibitor molecules
AU2010362444B2 (en) 2010-10-14 2015-08-06 Xigen Inflammation Ltd. Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
EP2675409A4 (en) * 2011-02-18 2015-04-08 Otonomy Inc PREVENTING AND RESTORING MEDICAMENT-INDUCED OTOTOXICITY
MX2014006399A (es) * 2011-11-30 2015-04-10 Xigen Inflammation Ltd Uso de inhibidores de peptidos con celulas permeables de la via para transduccion de señal de jnk para el tratamiento de la queratoconjuntivitis seca.
WO2013091670A1 (en) 2011-12-21 2013-06-27 Xigen S.A. Novel jnk inhibitor molecules for treatment of various diseases
WO2014206426A1 (en) * 2013-06-26 2014-12-31 Xigen Inflammation Ltd. New use for jnk inhibitor molecules for treatment of various diseases
WO2015197097A1 (en) 2014-06-26 2015-12-30 Xigen Inflammation Ltd. New use for jnk inhibitor molecules for treatment of various diseases
ES2870085T3 (es) 2013-06-26 2021-10-26 Xigen Inflammation Ltd Inhibidores peptídicos permeables a células de la ruta de transducción de señales de JNK para el tratamiento de la cistitis
WO2014206427A1 (en) 2013-06-26 2014-12-31 Xigen Inflammation Ltd. New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
GB201719520D0 (en) * 2017-11-24 2018-01-10 Univ College Cardiff Consultants Ltd Neuroprotectvie peptide
CN109182250A (zh) * 2018-09-30 2019-01-11 山东省立医院 一种小鼠耳蜗毛细胞培养方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US817457A (en) * 1906-01-18 1906-04-10 Kelley M Turner Head band or support for telephone-receivers.
US1447969A (en) * 1922-05-12 1923-03-13 Brandes Inc C Telephone head set
US4048453A (en) * 1976-02-11 1977-09-13 Gustave Seidel Telephone handset support device
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
JP2752788B2 (ja) 1989-01-23 1998-05-18 カイロン コーポレイション 感染および過剰増殖障害の為の組換え療法
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
US5804604A (en) * 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US5670617A (en) * 1989-12-21 1997-09-23 Biogen Inc Nucleic acid conjugates of tat-derived transport polypeptides
DE4005783A1 (de) * 1990-02-23 1991-09-05 Andreas Suckert Kopfhalterung fuer telefonhoerer
CA2135642C (en) * 1992-08-21 1999-12-14 James G. Barsoum Tat-derived transport polypeptides
KR950703640A (ko) 1992-10-09 1995-09-20 가일 케이,나우톤. 간 보존 세포(liver reserve cells)
WO1996034093A1 (en) * 1995-04-25 1996-10-31 Baxter International Inc. Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
BR9610058A (pt) 1995-07-28 1999-07-27 Marie Curie Cancer Care Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
US5689558A (en) * 1996-03-25 1997-11-18 Osgood; Alan G. Telephone handset holder
US5880261A (en) * 1997-04-03 1999-03-09 Waeber; Gerard Transcription factor Islet-Brain 1 (IB1)
US5828749A (en) * 1997-04-04 1998-10-27 Brodskiy; Arkadiy Phone holder kit
US6043083A (en) * 1997-04-28 2000-03-28 Davis; Roger J. Inhibitors of the JNK signal transduction pathway and methods of use
EP0897002A3 (en) * 1997-08-14 2001-10-04 Smithkline Beecham Plc U62317, a protein having a JNK-binding domain
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
CA2328457A1 (en) * 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
WO2000018407A1 (en) * 1998-09-25 2000-04-06 Cephalon, Inc. Methods for preventing/treating damage to sensory hair cells and cochlear neurons
US6610820B1 (en) * 1999-10-12 2003-08-26 University Of Lausanne Cell-permeable peptide inhibitors of the JNK signal transduction pathway
US20010046489A1 (en) * 1999-12-06 2001-11-29 Habener Joel E. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US20040014212A1 (en) * 2000-10-17 2004-01-22 Elliott Robert Bartlett Preparation and xenotransplantation or porcine islets
JP4234999B2 (ja) * 2001-04-06 2009-03-04 トマス ジェファソン ユニバーシティ 治療標的としてのｈｉｖ−１ｖｉｆタンパク質の多量体形成
DE10117281A1 (de) * 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz

Similar Documents

Publication Publication Date Title
JP2006501165A5 (https=)
ES2732252T3 (es) Procedimientos para tratar diabetes y/o promover la supervivencia de los islotes pancreáticos después del trasplante
CZ20014289A3 (cs) Nové pouľití sloučenin jako antibakteriálních činidel
CA2332817A1 (en) Il-6 antagonist peptides
Barbounis et al. Control of irinotecan-induced diarrhea by octreotide after loperamide failure
CA2488695A1 (en) Cell-permeable peptide inhibitors of the jnk signal transduction pathway
CA2442909A1 (en) Multimerization of hiv-1 vif protein as a therapeutic target
JP2018502836A5 (https=)
WO2010107476A1 (en) Inhibiting gsnor
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
SE9800550D0 (sv) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
JP2021509916A5 (https=)
JP2011517675A5 (https=)
JP2011506436A (ja) 細胞傷害性ｔリンパ球抗原４（ｃｔｌａ４）に対する抗体と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
RU2016110153A (ru) Новые пептиды и их аналоги для применения при лечении мукозита полости рта
ATE383850T1 (de) Pulver enthaltend neuartige oligosaccharidgemische und verfahren zu deren herstellung
JP2021500409A5 (https=)
JP2009530359A (ja) 腫瘍成長の阻害
JP2025027020A (ja) 患者において血清リン酸塩を低下させるための組み合わせ
CN100418532C (zh) 治疗多种疾病的NF-κB化合物抑制剂
JP2021518374A (ja) メラノーマを治療するための方法
KR20080099234A (ko) 콤브레타스타틴 및 항암제를 포함하는 조합물
JP2019108277A5 (https=)
AU5158000A (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
CA2493859A1 (en) Preventive/remedy for arteriosclerosis comprising adiponectin